Cargando…
A novel built-in adjuvant metallothionein-3 aids protein antigens to induce rapid, robust, and durable immune responses
Adjuvants are crucial components of vaccines that can enhance and modulate antigen-specific immune responses. Herein, we reported for the first time that human metallothionein-3 (MT3), a low molecular weight cysteine-rich metal-binding protein, was a novel promising adjuvant candidate that could hel...
Autores principales: | Yin, Ying, Gu, Yanfei, Zai, Xiaodong, Li, Ruihua, Zhu, Xinjie, Yu, Rui, Zhang, Jun, Wang, Shuyi, Zhang, Yue, Lin, Jian, Xu, Junjie, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680554/ https://www.ncbi.nlm.nih.gov/pubmed/36426348 http://dx.doi.org/10.3389/fimmu.2022.1024437 |
Ejemplares similares
-
A novel Galleria mellonella experimental model for zoonotic pathogen Brucella
por: Wang, Shuyi, et al.
Publicado: (2023) -
Precise modification of the surface charge of antigen enhances vaccine immunogenicity
por: Zai, Xiaodong, et al.
Publicado: (2023) -
Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses
por: Du, Jing-Jing, et al.
Publicado: (2020) -
RBD(206)-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern
por: Zhou, Chuge, et al.
Publicado: (2021) -
Application of built-in adjuvants for epitope-based vaccines
por: Lei, Yao, et al.
Publicado: (2019)